Sidra Medicine unveils Qatar’s first advanced gene-editing therapy for blood disorders
Have anything to say about this article?
You can report: fake news, misinformation, error, more information, additional data, etc.
CommentYour comment has been sent successfuly! Thank you.
Sidra Medicine unveils Qatar’s first advanced gene-editing therapy for blood disorders
Doha, Qatar: A major step forward in treating inherited blood disorders in Qatar Sidra Medicine a member of Qatar Foundation is now offering a new gene therapy to eligible patients. The hospital has been qualified by Vertex Pharmaceuticals to administer Casgevy, a one-time treatment designed for pa»»»
Sidra Medicine introduces gene-editing therapy for sickle cell disease and thalassaemia
Tribune News Network Doha Sidra Medicine, a member of Qatar Foundation, has been qualified by Vertex Pharmaceuticals as one of a limited number of hospitals in the world to administer Casgevy, a groundbreaking, one-time CRISPR/Cas9-based gene therapy treatment. Casgevy is now available in Qatar for»»»
Have anything to say about this article?
You can report: fake news, misinformation, error, more information, additional data, etc.
Comment